Подробнее о клинических исследованиях, которые подтверждают эффективность и безопасность штаммов, использующихся в наших продуктах, Вы можете узнать в следующих статьях:
Drago L., et al. (2012). Changing of Fecal Flora and Clinical Effect of L. salivarius LS01 in Adults With Atopic Dermatitis. J Clin Gastroenterol, 46: 56-63. DOI: 10.1097/MCG.0b013e318265ef38.
Drago L., et al. (2011). Effects of Lactobacillus salivarius LSOI (DSM 22775) Treatment ON Adult Atopic Dermatitis: a Randomized Placebo-controlled Study. Int J Immunopathol Pharmacol, 24(4): 1037-1048. DOI: 10.1177/039463201102400421.
Iemoli E., et al. (2012). Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol, 46: 22-40.
Niccoli A., et al. (2014). Preliminary Results on Clinical Effects of Probiotic Lactobacillus salivarius LS01 in Children Affected by Atopic Dermatitis. J Clin Gastroenterol, 48: 34-36.
Nicola S., et al. (2010). Interaction between probiotics and human immune cells The prospective anti-inflammatory activity of Bifidobacterium breve BR03. AgroFOOD, 21(2): 44-47.
Bonavina L., et al. (2019). Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorder. Acta bio-medica : Atenei Parmensis, 90(7-S): 8–12. DOI: https://doi.org/10.23750/abm.v90i7-S.8649.
Mogna L., et al. (2012). Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains. J Clin Gastroenterol, 46: 29-32.
Savino F., et al. (2011). Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiology, 11: 157. DOI: https://doi.org/10.1186/1471-2180-11-157.
Amoruso A., et al. (2019). A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus Plantarum LP01 (LMG P-21021). J Prob Health, 7:214. DOI: 10.35248/2329-8901.19.7.214.
Deidda F., et al. (2020). How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 8(2): 216
.
Drago L., et al. Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics. Allergy Asthma Immunol Res., 7(4): 409-413. DOI: https://doi.org/10.4168/aair.2015.7.4.409.
Mogna L., et al. (2018). Micronized Cells of the Probiotic Strain Bifidobacterium lactis BS01 Activate Monocyte Polarization: A New Approach. J Clin Gastroenterol, 52: 57-61.